| Name | Estrogen receptor antagonist 2 |
|---|
| Description | Estrogen receptor antagonist 2 is a selective estrogen receptor downregulator. Estrogen (E2) and estrogen alpha receptor (ERα) are important drivers of breast cancer development. Estrogen receptor antagonist 2 has the potential for the research of breast cancer diseases (extracted from patent WO2021228210A1, compound 3)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Gu Peng, et al. Pyrrolidine compounds and their applications. Patent WO2021228210A1. |
| Molecular Formula | C26H31F4N5 |
|---|---|
| Molecular Weight | 489.55 |